These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 31834673)
1. Therapies that are available and under development for Duchenne muscular dystrophy: What about lung function? Gogou M; Pavlou E; Haidopoulou K Pediatr Pulmonol; 2020 Feb; 55(2):300-315. PubMed ID: 31834673 [TBL] [Abstract][Full Text] [Related]
2. Effects of glucocorticoids and idebenone on respiratory function in patients with duchenne muscular dystrophy. Buyse GM; Goemans N; van den Hauwe M; Meier T Pediatr Pulmonol; 2013 Sep; 48(9):912-20. PubMed ID: 23129412 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial. Buyse GM; Voit T; Schara U; Straathof CSM; D'Angelo MG; Bernert G; Cuisset JM; Finkel RS; Goemans N; McDonald CM; Rummey C; Meier T; Lancet; 2015 May; 385(9979):1748-1757. PubMed ID: 25907158 [TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Manzur AY; Kuntzer T; Pike M; Swan A Cochrane Database Syst Rev; 2004; (2):CD003725. PubMed ID: 15106215 [TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Manzur AY; Kuntzer T; Pike M; Swan A Cochrane Database Syst Rev; 2008 Jan; (1):CD003725. PubMed ID: 18254031 [TBL] [Abstract][Full Text] [Related]
6. Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study. McDonald CM; Henricson EK; Abresch RT; Duong T; Joyce NC; Hu F; Clemens PR; Hoffman EP; Cnaan A; Gordish-Dressman H; Lancet; 2018 Feb; 391(10119):451-461. PubMed ID: 29174484 [TBL] [Abstract][Full Text] [Related]
12. Effect of long-term steroids on cough efficiency and respiratory muscle strength in patients with Duchenne muscular dystrophy. Daftary AS; Crisanti M; Kalra M; Wong B; Amin R Pediatrics; 2007 Feb; 119(2):e320-4. PubMed ID: 17272595 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of Idebenone to Preserve Respiratory Function above Clinically Meaningful Thresholds for Forced Vital Capacity (FVC) in Patients with Duchenne Muscular Dystrophy. Mayer OH; Leinonen M; Rummey C; Meier T; Buyse GM; J Neuromuscul Dis; 2017; 4(3):189-198. PubMed ID: 28869486 [TBL] [Abstract][Full Text] [Related]
14. An Overview of Recent Therapeutics Advances for Duchenne Muscular Dystrophy. Mah JK Methods Mol Biol; 2018; 1687():3-17. PubMed ID: 29067652 [TBL] [Abstract][Full Text] [Related]
16. Treatment effect of idebenone on inspiratory function in patients with Duchenne muscular dystrophy. Buyse GM; Voit T; Schara U; Straathof CS; D'Angelo MG; Bernert G; Cuisset JM; Finkel RS; Goemans N; Rummey C; Leinonen M; Mayer OH; Spagnolo P; Meier T; McDonald CM; Pediatr Pulmonol; 2017 Apr; 52(4):508-515. PubMed ID: 27571420 [TBL] [Abstract][Full Text] [Related]
17. Eteplirsen in the treatment of Duchenne muscular dystrophy. Lim KR; Maruyama R; Yokota T Drug Des Devel Ther; 2017; 11():533-545. PubMed ID: 28280301 [TBL] [Abstract][Full Text] [Related]
18. Surgery for scoliosis in Duchenne muscular dystrophy. Cheuk DK; Wong V; Wraige E; Baxter P; Cole A Cochrane Database Syst Rev; 2013 Feb; (2):CD005375. PubMed ID: 23450561 [TBL] [Abstract][Full Text] [Related]